Rankings
▼
Calendar
ZVRA Q2 2025 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ZVRA
Zevra Therapeutics, Inc.
$618M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$26M
+481.7% YoY
Gross Profit
$14M
52.2% margin
Operating Income
-$71M
-274.5% margin
Net Income
$75M
288.7% margin
EPS (Diluted)
$1.36
QoQ Revenue Growth
+26.9%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$256M
Total Liabilities
$139M
Stockholders' Equity
$117M
Cash & Equivalents
$48M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$26M
$4M
+481.7%
Gross Profit
$14M
$876,000
+1441.3%
Operating Income
-$71M
-$24M
-198.5%
Net Income
$75M
-$20M
+474.9%
← FY 2025
All Quarters
Q3 2025 →